Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Andrea

Showing results (41-50 of 385) with videos related to

Pageof 39
Sort By:
Annals of Surgical Oncology|October 9, 2013
Mucinous tumor of the appendix with limited peritoneal spread: is there a role for expectant observation?Francis S W Zih, Nathalie Wong-Chong, Claire Hummel, et al.
Molecular Therapy Oncolytics|April 28, 2016
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasisJessica G Tong, Yudith Ramos Valdes, John W Barrett, et al.
Plos One|January 13, 2010
Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude miceJari E Heikkilä, Markus J V Vähä-Koskela, Janne J Ruotsalainen, et al.
International Journal of Cancer|July 30, 2013
Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosisKathryn Ottolino-Perry, Nan Tang, Renee Head, et al.
World Journal of Surgery|May 8, 2003
Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structuresTeresa J Chan, Steven K Libutti, J Andrea McCart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotideJ Andrea McCart, Navneet Mehta, Deborah Scollard, et al.
Human Gene Therapy|January 18, 2006
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primatesArpana M Naik, Sricharan Chalikonda, J Andrea McCart, et al.
Journal of Virology|November 13, 2009
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer modelsKilian Guse, Marta Sloniecka, Iulia Diaconu, et al.
Molecular Cancer Therapeutics|March 12, 2009
Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injectionSeverine Loisel-Meyer, Tania Felizardo, Jacopo Mariotti, et al.
Pageof 39

Showing results (41-50 of 385) with videos related to

Sort By:
Pageof 39
Annals of Surgical Oncology|October 9, 2013
Mucinous tumor of the appendix with limited peritoneal spread: is there a role for expectant observation?Francis S W Zih, Nathalie Wong-Chong, Claire Hummel, et al.
Molecular Therapy Oncolytics|April 28, 2016
Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasisJessica G Tong, Yudith Ramos Valdes, John W Barrett, et al.
Plos One|January 13, 2010
Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude miceJari E Heikkilä, Markus J V Vähä-Koskela, Janne J Ruotsalainen, et al.
International Journal of Cancer|July 30, 2013
Tumor vascularization is critical for oncolytic vaccinia virus treatment of peritoneal carcinomatosisKathryn Ottolino-Perry, Nan Tang, Renee Head, et al.
World Journal of Surgery|May 8, 2003
Persistent primary hyperparathyroidism caused by adenomas identified in pharyngeal or adjacent structuresTeresa J Chan, Steven K Libutti, J Andrea McCart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2009
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamideXue Qing Lun, Ji-Hyun Jang, Nan Tang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 1, 2004
Oncolytic vaccinia virus expressing the human somatostatin receptor SSTR2: molecular imaging after systemic delivery using 111In-pentetreotideJ Andrea McCart, Navneet Mehta, Deborah Scollard, et al.
Human Gene Therapy|January 18, 2006
Intravenous and isolated limb perfusion delivery of wild type and a tumor-selective replicating mutant vaccinia virus in nonhuman primatesArpana M Naik, Sricharan Chalikonda, J Andrea McCart, et al.
Journal of Virology|November 13, 2009
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer modelsKilian Guse, Marta Sloniecka, Iulia Diaconu, et al.
Molecular Cancer Therapeutics|March 12, 2009
Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injectionSeverine Loisel-Meyer, Tania Felizardo, Jacopo Mariotti, et al.
Pageof 39